173 related articles for article (PubMed ID: 19774682)
1. Investigation of the occurrence of torque tenovirus in malignant and potentially malignant disorders associated with human papillomavirus.
Fehér E; Gáll T; Murvai M; Kis A; Boda R; Sápy T; Tar I; Gergely L; Szarka K
J Med Virol; 2009 Nov; 81(11):1975-81. PubMed ID: 19774682
[TBL] [Abstract][Full Text] [Related]
2. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.
Ha PK; Pai SI; Westra WH; Gillison ML; Tong BC; Sidransky D; Califano JA
Clin Cancer Res; 2002 May; 8(5):1203-9. PubMed ID: 12006539
[TBL] [Abstract][Full Text] [Related]
3. Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions.
Furrer VE; Benitez MB; Furnes M; Lanfranchi HE; Modesti NM
J Oral Pathol Med; 2006 Jul; 35(6):338-44. PubMed ID: 16762014
[TBL] [Abstract][Full Text] [Related]
4. Incidence of human papillomavirus infection in oral leukoplakia. Indications for a viral aetiology.
Cianfriglia F; Di Gregorio DA; Cianfriglia C; Marandino F; Perrone Donnorso R; Vocaturo A
J Exp Clin Cancer Res; 2006 Mar; 25(1):21-8. PubMed ID: 16761614
[TBL] [Abstract][Full Text] [Related]
5. High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma.
Szládek G; Juhász A; Kardos G; Szoke K; Major T; Sziklai I; Tar I; Márton I; Kónya J; Gergely L; Szarka K
J Clin Pathol; 2005 Apr; 58(4):402-5. PubMed ID: 15790705
[TBL] [Abstract][Full Text] [Related]
6. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic.
Tachezy R; Klozar J; Saláková M; Smith E; Turek L; Betka J; Kodet R; Hamsíková E
Oral Dis; 2005 May; 11(3):181-5. PubMed ID: 15888110
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus (HPV) in head and neck cancer.
Syrjänen S
J Clin Virol; 2005 Mar; 32 Suppl 1():S59-66. PubMed ID: 15753013
[TBL] [Abstract][Full Text] [Related]
8. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of human papillomavirus types in cervical and oral cancers in central India.
Gheit T; Vaccarella S; Schmitt M; Pawlita M; Franceschi S; Sankaranarayanan R; Sylla BS; Tommasino M; Gangane N
Vaccine; 2009 Jan; 27(5):636-9. PubMed ID: 19056450
[TBL] [Abstract][Full Text] [Related]
10. Expression of keratin 13, 14 and 19 in oral hyperplastic and dysplastic lesions from Sudanese and Swedish snuff-dippers: association with human papillomavirus infection.
Ibrahim SO; Warnakulasuriya KA; Idris AM; Hirsch JM; Johnson NW; Johannessen AC
Anticancer Res; 1998; 18(1B):635-45. PubMed ID: 9584046
[TBL] [Abstract][Full Text] [Related]
11. Incidence rates for oral leukoplakia and lichen planus in a Japanese population.
Nagao T; Ikeda N; Fukano H; Hashimoto S; Shimozato K; Warnakulasuriya S
J Oral Pathol Med; 2005 Oct; 34(9):532-9. PubMed ID: 16138891
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review).
Campisi G; Panzarella V; Giuliani M; Lajolo C; Di Fede O; Falaschini S; Di Liberto C; Scully C; Lo Muzio L
Int J Oncol; 2007 Apr; 30(4):813-23. PubMed ID: 17332919
[TBL] [Abstract][Full Text] [Related]
13. Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples.
Majumder M; Indra D; Roy PD; Datta S; Ray JG; Panda CK; Roy B
J Oral Pathol Med; 2009 Feb; 38(2):174-80. PubMed ID: 18764855
[TBL] [Abstract][Full Text] [Related]
14. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
Parkin DM; Louie KS; Clifford G
Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
[TBL] [Abstract][Full Text] [Related]
15. Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions.
Acay RR; dos Santos E; de Sousa SO
Oral Oncol; 2008 Jul; 44(7):698-702. PubMed ID: 18061529
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma viruses in oral lesions.
Sand L; Jalouli J; Larsson PA; Hirsch JM
Anticancer Res; 2000; 20(2B):1183-8. PubMed ID: 10810419
[TBL] [Abstract][Full Text] [Related]
17. Papillary lesions of the oral cavity: relationship to human papillomaviruses.
Eversole LR
J Calif Dent Assoc; 2000 Dec; 28(12):922-7. PubMed ID: 11323946
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada.
Pintos J; Black MJ; Sadeghi N; Ghadirian P; Zeitouni AG; Viscidi RP; Herrero R; Coutlée F; Franco EL
Oral Oncol; 2008 Mar; 44(3):242-50. PubMed ID: 17467327
[TBL] [Abstract][Full Text] [Related]
19. [Role of human papillomavirus in carcinogenesis of head and neck cancer].
Nováková V; Laco J
Klin Onkol; 2008; 21(4):141-8. PubMed ID: 19102219
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection.
Bagan JV; Jimenez Y; Murillo J; Gavaldá C; Poveda R; Scully C; Alberola TM; Torres-Puente M; Pérez-Alonso M
J Oral Maxillofac Surg; 2007 Jan; 65(1):46-9. PubMed ID: 17174763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
